Related references
Note: Only part of the references are listed.Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database
F. Cohen Aubart et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Tocilizumab-induced sarcoidosis-like reaction in a patient with giant cell arteritis. Clinical implications of a paradoxical phenomenon
Grigorios Theodosiou et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Refractory Sarcoidosis: A Review
Thomas El Jammal et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Drug-Induced Sarcoidosis-Like Reactions
Amit Chopra et al.
CHEST (2018)
Cutaneous sarcoidosis in a patient with rheumatoid arthritis receiving tocilizumab
Yuki Shono et al.
JOURNAL OF DERMATOLOGY (2018)
Une sarcoïdose sous tocilizumab : à propos d’un cas
J. N’guyen Van Thanh dit Bayard et al.
REVUE DE MEDECINE INTERNE (2018)
Trial of Tocilizumab in Giant-Cell Arteritis
J. H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tocilizumab (Actemra)
Martin Sheppard et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Mechanism of granuloma formation in sarcoidosis
Priya Sakthivel et al.
CURRENT OPINION IN HEMATOLOGY (2017)
IFN-γ-Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells
Joris Ramstein et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
T-cell immunology in sarcoidosis: Disruption of a delicate balance between helper and regulatory T-cells
Caroline E. Broos et al.
CURRENT OPINION IN PULMONARY MEDICINE (2016)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Sarcoidosis Induced by Tocilizumab: A Paradoxical Event?
Anaiz Nutz et al.
JOURNAL OF RHEUMATOLOGY (2013)
Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis
W Ma-Krupa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow
JI Bleier et al.
JOURNAL OF IMMUNOLOGY (2004)
Lung injury linked to etanercept therapy
L Peno-Green et al.
CHEST (2002)
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
P Chomarat et al.
NATURE IMMUNOLOGY (2000)
Share Paper
